核磁共振代谢组学方法研究雷公藤红素对大鼠糖尿病溃疡促愈合作用机制

摘要

采用腹腔注射链脲佐菌素结合打孔器皮肤烫伤构建SD大鼠糖尿病溃疡模型,随机分为正常创面生理盐水处理组、糖尿病溃疡模型生理盐水处理组、糖尿病溃疡模型雷公藤红素处理组,溃疡创面持续给药处理14d,利用基于核磁共振的代谢组学方法研究雷公藤红素处理后大鼠糖尿病溃疡组织代谢特征,并结合形态观察计算溃疡愈合率及组织病理学检测(HE染色、Masson染色)技术研究大鼠糖尿病溃疡的愈合情况,揭示雷公藤红素对大鼠糖尿病溃疡的治疗作用及其机制.研究结果表明,雷公藤红素可诱导大鼠溃疡创面上皮再生化,调节炎性细胞浸润和胶原纤维分布,促进溃疡创面愈合.经偏最小二乘法分析,筛选并鉴定出20种潜在内源性差异代谢物.代谢通路分析表明,雷公藤红素能够显著提高溃疡组织三羧酸循环水平,促进其能量供应,加快蛋白合成,改善线粒体功能和氧化应激水平,加速皮肤组织的自我修复能力,促进糖尿病溃疡的愈合.本研究为雷公藤红素作为治疗糖尿病溃疡新药研究提供了参考.%The experimental SD rats were randomly divided into normal control group (Con group),diabetic ulcer model group (DM group) and Celastrol group (Cel group).Except the control group,diabetic ulceration rat models were established by intraperitoneal injection of streptozotocin along with skin scald.And then,each group was treated by spraying the saline solution on the affected skin with (Cel group) or without (Con group and DM group) Cel (q.d.×14 d).Nuclear magnetic resonance (NMR)-based metabonomic analysis was applied to detect metabolic characteristics,accompanied by healing rate calculation and HE and Masson staining to study therapeutic effect of celastrol on accelerated healing of skin wounds of diabetic ulceration rats,which could be used to elucidate therapeutic effects of celastrol on the rat diabetic ulceration and its mechanism.The results showed that celastrol could induce epithelial regeneration of the rat ulcer wound,regulate the infiltration of inflammatory cells and the distribution of collagen fibers,and promote the healing of the ulcer wound.About 20 endogenous potential differential metabolites were screened and identified by partial least square analysis.Metabolic pathway analysis was carried out to show that celastrol can significantly recovery the level of the tricarboxylic acid cycle,promote its energy supply,accelerate the protein synthesis,improve mitochondrial dysfunction and oxidative stress,and accelerate the self-repair ability of skin tissue.Celastrol can promote the healing of ulcers skins of the diabetic rats,which contribute to experimental basis of the drugs for the treatment of diabetic ulcers.